CastleKnight Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
666,600
+524,400
| +369% | +$8.79M | 0.32% | 33 |
|
|
2025
Q1 | $2.19M | Sell |
142,200
-25,200
| -15% | -$387K | 0.09% | 110 |
|
|
2024
Q4 | $3.69M | Sell |
167,400
-51,500
| -24% | -$1.14M | 0.11% | 74 |
|
|
2024
Q3 | $3.94M | Sell |
218,900
-51,600
| -19% | -$930K | 0.16% | 59 |
|
|
2024
Q2 | $4.4M | Sell |
270,500
-7,300
| -3% | -$119K | 0.22% | 45 |
|
|
2024
Q1 | $3.92M | Buy |
277,800
+42,100
| +18% | +$594K | 0.23% | 48 |
|
|
2023
Q4 | $2.46M | Buy |
+235,700
| New | +$2.46M | 0.13% | 77 |
|